Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 conference, Drs. Laura Coates and Atul Deodhar debated whether axial psoriatic arthritis (axPsA) is the same as ankylosing spondylitis (AS) with psoriasis. Dr. Coates argued that AS represents a spectrum...

Bibliográfalaš dieđut
Váldodahkkit:	Coates, LC, Deodhar, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Journal of Rheumatology Publishing 2023

Geahča maid

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
Dahkki: Alba Erra, et al.
Almmustuhtton: (2022-11-01)

Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
Dahkki: Elena Conesa-Nicolás, et al.
Almmustuhtton: (2021-01-01)

Modern imaging techniques in the diagnosis of axial spondylitis: similarities and differences between axial psoriatic arthritis and ankylosing spondylitis
Dahkki: A. V. Sukhinina, et al.
Almmustuhtton: (2024-02-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
Dahkki: Lubrano E, et al.
Almmustuhtton: (2016-10-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
Dahkki: E. E. Gubar, et al.
Almmustuhtton: (2023-08-01)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Dahkki: Coates, L, et al.
Almmustuhtton: (2016)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
Dahkki: A. P. Rebrov, et al.
Almmustuhtton: (2015-03-01)

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
Dahkki: Andrea Rubbert-Roth, et al.
Almmustuhtton: (2023-11-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Dahkki: M. Rossini, et al.
Almmustuhtton: (2015-03-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
Dahkki: T. V. Dubinina, et al.
Almmustuhtton: (2023-02-01)

Identification of psoriatic arthritis in patients with psoriasis
Dahkki: Coates, LC, et al.
Almmustuhtton: (2023)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
Dahkki: Vivekanantham, A, et al.
Almmustuhtton: (2024)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
Dahkki: Chia-Jung Tsai, et al.
Almmustuhtton: (2023-09-01)

The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
Dahkki: Ahmet Karataş, et al.
Almmustuhtton: (2020-10-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
Dahkki: Viola Sacchi, et al.
Almmustuhtton: (2010-06-01)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
Dahkki: Ashley Elliott, et al.
Almmustuhtton: (2019-06-01)

How should we define disease and outcomes in axial psoriatic arthritis?
Dahkki: Coates, LC
Almmustuhtton: (2021)

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
Dahkki: Bolge SC, et al.
Almmustuhtton: (2017-03-01)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Dahkki: Iain B McInnes, et al.
Almmustuhtton: (2020-02-01)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Dahkki: Lars Erik Kristensen, et al.
Almmustuhtton: (2024-05-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Dahkki: M. Elaine Husni, et al.
Almmustuhtton: (2022-03-01)

Ankylosing spondylitis-axial spondyloarthritis
Dahkki: Aanand Narayan Malaviya
Almmustuhtton: (2017-01-01)

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Dahkki: A. Deodhar, et al.
Almmustuhtton: (2019-05-01)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
Dahkki: Braun, J, et al.
Almmustuhtton: (2023)

Methotrexate in psoriasis and psoriatic arthritis
Dahkki: Coates, L, et al.
Almmustuhtton: (2020)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
Dahkki: Colombo GL, et al.
Almmustuhtton: (2018-08-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Dahkki: Alexis Ogdie, et al.
Almmustuhtton: (2024-09-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
Dahkki: Sumera Ghani, et al.
Almmustuhtton: (2023-06-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
Dahkki: Nikolay N. Murashkin, et al.
Almmustuhtton: (2020-12-01)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Dahkki: Peter Nash, et al.
Almmustuhtton: (2023-10-01)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Dahkki: Gia Deyab, et al.
Almmustuhtton: (2017-01-01)

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
Dahkki: Peter Nash, et al.
Almmustuhtton: (2023-02-01)

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset
Dahkki: Sarah B. Lieber, et al.
Almmustuhtton: (2022-04-01)

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study
Dahkki: Joachim Sieper, et al.
Almmustuhtton: (2019-06-01)

Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Dahkki: Fatma Mohammed Aboud, et al.
Almmustuhtton: (2023-03-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
Dahkki: Gerd R. Burmester, et al.
Almmustuhtton: (2024-04-01)

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis
Dahkki: C. Brock, et al.
Almmustuhtton: (2021-01-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
Dahkki: Krzysztof Bonek, et al.
Almmustuhtton: (2022-04-01)

Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis
Dahkki: Qiang Lian, et al.
Almmustuhtton: (2022-10-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
Dahkki: Ehab F. Girbash, et al.
Almmustuhtton: (2023-01-01)